Table 1.
Baseline characteristics of the CRS type 1 and AHF patients and clinical parameters
| CRS type 1 patients (n = 11) | AHF patients (n = 29) | |
|---|---|---|
| Age, years | 74.0 ± 13.1 | 73.6 ± 9.5 |
| Weight, kg | 77 (67–85) | 75 (64–88) |
| Diabetes, % | 63 | 41 |
| Hypertension, % | 90 | 93 |
| Peripheral vascular disease, % | 42 | 38 |
| Cardiovascular disease, % | 19 | 16 |
| Obesity, % | 23 | 20 |
| Dyslipidemia, % | 43 | 37 |
| Death, % | 27 | 3.4 |
| Creatinine, mg/dl | 0.96 (0.88–1.02) | 0.98 (0.87–1.15) |
| eGFR, ml/min/1.73 m2 | 62 (55–75) | 67 (53–82) |
| Mean arterial pressure, mm Hg | 100 (89.2–115.8) | 103 (93.3–120.8) |
| Ejection fraction, % | 35 (25.0–51.0) | 35 (24.0–48.0) |
| BNP, pg/ml | 695 (408–1,837) | 632 (398–946) |
| Troponin I, ng/ml | 0.07 (0.04–0.26) | 0.07 (0.04–0.27) |
| Hemoglobin, g/dl | 11.4 (9.7–13.0) | 11.1 (13.6–14.2) |
| Albumin, g/l | 4.3 (4.0–4.4) | 4.0 (4.2–4.4) |
| Urea, mg/dl | 73 (55–109) | 66 (41–91) |
| NGAL, ng/ml | 228 (164–391) | 197 (145–282) |
| White blood cell count, 109/l | 11.6 (7.3–15.5) | 10.3 (8.3–13.3) |
| Neutrophils, % | 79.8 (72.4–84.7) | 74.1 (68.3–81.6) |
| C-reactive protein, mg/dl | 4.0 (2.1–8.1) | 3.3 (1.0–9.7) |
Values denote means ± SD or medians (IQR) unless specified otherwise.